AVE Insider Trading

Insider Ownership Percentage: 34.40%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Avecho Biotechnology Insider Trading History Chart

This chart shows the insider buying and selling history at Avecho Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avecho Biotechnology Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 06/1/2021 01:08 PM ET

This chart shows the closing price history over time for AVE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Avecho Biotechnology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2023Matthew McNamaraInsiderIssued2,499,999A$0.00A$10,000.00
5/10/2023Ross MurdochInsiderIssued1,666,666A$0.01A$10,000.00
9/10/2021Gregory (Greg) CollierInsiderExpiry2,250,000A$0.02A$40,500.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Avecho Biotechnology (ASX:AVE)

3.19% of Avecho Biotechnology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Avecho Biotechnology Limited, a biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. The company was incorporated in 1992 and is based in Clayton, Australia.
Read More on Avecho Biotechnology

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A



Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Avecho Biotechnology?

Avecho Biotechnology's top insider investors include:
  1. Matthew McNamara (Insider)
  2. Ross Murdoch (Insider)
Learn More about top insider investors at Avecho Biotechnology.